Adalimumab/certolizumab-pegolTuberculosis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1826卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84467-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：20 / 20

相关论文

共 50 条

[41] Adalimumab/infliximabParadoxical psoriasis: 2 case reports
Reactions Weekly, 2016, 1615 (1) : 15 - 15
[42] Adalimumab/etanercept/infliximabPsoriasis: 2 case reports
Reactions Weekly, 2016, 1593 (1) : 17 - 17
[43] Adalimumab/infliximabAutoimmune neutropenia: 2 case reports
Reactions Weekly, 2012, 1416 (1) : 6 - 6
[44] Adalimumab/infliximabExfoliative erythroderma: 2 case reports
Reactions Weekly, 2016, 1601 (1) : 20 - 20
[45] Adalimumab/etanerceptHepatic injury: 2 case reports
Reactions Weekly, 2014, 1483 (1) : 7 - 7
[46] Adalimumab/etanerceptPlantar fibromatosis: 2 case reports
Reactions Weekly, 2017, 1657 (1) : 16 - 16
[47] Adalimumab/infliximabCytomegalovirus colitis: 2 case reports
Reactions Weekly, 2021, 1885 (1) : 29 - 29
[48] Adalimumab/etanerceptPalmoplantar pustulosis: 2 case reports
Reactions Weekly, 2012, 1383 (1) : 6 - 6
[49] Adalimumab/infliximabCutaneous sarcoidosis: 2 case reports
Reactions Weekly, 2010, 1308 (1) : 8 - 9
[50] Adalimumab/infliximabDisseminated histoplasmosis: 2 case reports
Reactions Weekly, 2016, 1587 (1) : 19 - 19

← 1 2 3 4 5 →